96 Participants Needed

Smoking Cessation Intervention for Reducing Cigarette Use

CS
Overseen ByChristine Sheffer
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Roswell Park Cancer Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial evaluates the effectiveness of active episodic future thinking (EFT) stimuli for reducing cigarette consumption in cigarette smokers. EFT is an innovative framing method shown to significantly activate brain regions involved in future thinking, planning, and other executive functions. Active EFT stimuli are positive events, unrelated to smoking, that participants anticipate, look forward to, and can vividly imagine happening up to 1 year in the future. Control EFT stimuli are positive past events, unrelated to smoking, that participants can vividly remember happening in the recent past. Active EFT stimuli may help reduce cigarette consumption among cigarette smokers by exposing them to personally relevant future oriented stimuli.

Will I have to stop taking my current medications?

The trial requires that you are not currently using nicotine replacement therapy, bupropion, or varenicline. If you are using these, you would need to stop before participating.

What data supports the effectiveness of the treatment for smoking cessation?

Research shows that Episodic Future Thinking (EFT), which involves imagining positive future events, can reduce cigarette craving and delay discounting (the tendency to prefer smaller immediate rewards over larger future ones), which are both linked to smoking behavior. This suggests that EFT may help people quit smoking by making them less impulsive and reducing their desire to smoke.12345

Is episodic future thinking (EFT) safe for use in smoking cessation interventions?

Episodic future thinking (EFT) has been studied as a method to help reduce cigarette craving and demand, and no significant safety concerns have been reported in the research available. It is generally considered safe for use in smoking cessation interventions.12367

How is the Smoking Cessation Intervention (EFT) different from other smoking cessation treatments?

The Smoking Cessation Intervention using Episodic Future Thinking (EFT) is unique because it involves imagining future scenarios to reduce cigarette use, which is different from traditional methods like nicotine replacement or counseling. This approach focuses on changing how individuals think about their future, potentially making it a novel way to address smoking habits.89101112

Research Team

CS

Christine Sheffer

Principal Investigator

Roswell Park

Eligibility Criteria

This trial is for cigarette smokers who smoke at least 10 cigarettes daily, do not use other tobacco products regularly, have a smartphone with texting ability, and can vividly imagine visual images. People using nicotine replacements or certain medications, those who've used drugs of abuse recently, or live with someone in the study cannot join.

Inclusion Criteria

Smoke >= 10 cigarettes daily
Score > 32 on the Vividness of Visual Imagery Questionnaire (VVIQ)
No regular use of other tobacco products
See 3 more

Exclusion Criteria

I am currently using nicotine replacement, bupropion, or varenicline.
Use of drugs of abuse in the past 30 days
Living in the same household as a participant already enrolled in this study
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either the active or control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor

4 weeks
Weekly visits (in-person or virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Medical Device Usage and Evaluation
  • Smoking Cessation Intervention
  • Smoking Cessation Intervention (control)
Trial Overview The trial tests if active episodic future thinking (EFT)—imagining positive future events—can help smokers cut down on smoking compared to recalling past positive events. It also assesses how well participants engage with this method through their smartphones.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1 (active EFT)Experimental Treatment2 Interventions
Participants receive the active EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.
Group II: Arm II (control EFT)Active Control2 Interventions
Participants receive the control EFT stimulus and use the iCOquit Smokerlyzer carbon monoxide monitor on study.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Roswell Park Cancer Institute

Lead Sponsor

Trials
427
Recruited
40,500+

Findings from Research

The combination of cognitive-behavioral treatment (CBT) and episodic future thinking (EFT) for smoking cessation in a group of 29 smokers with substance use disorders was found to be acceptable, with a high satisfaction rating of 8.83 out of 10.
Despite the positive reception, adherence to the EFT component was low, with only 15.8% of participants practicing it as recommended, indicating a need for adjustments in future studies to enhance compliance and effectiveness.
Episodic future thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability.Aonso-Diego, G., González-Roz, A., Martínez-Loredo, V., et al.[2021]
Episodic future thinking (EFT) significantly reduces delay discounting and cigarette craving among smokers, suggesting it may help in smoking cessation efforts.
Imagining smoking-related illness (SRI) increased delay discounting but also reduced craving, indicating that while SRI can heighten the perceived value of immediate rewards, it may also help in managing cravings when combined with EFT.
Episodic Future Thinking about Smoking-Related Illness: A Preliminary Investigation of Effects on Delay Discounting, Cigarette Craving, and Cigarette Demand.Ruhi-Williams, P., King, MJ., Stein, JS., et al.[2022]
Episodic future thinking (EFT) shows promise as an intervention for reducing problematic substance use and substance use disorders, based on a systematic review of 16 studies that demonstrated benefits in self-reported and task-based outcomes.
The review highlights the need for further research to assess the feasibility, generalizability, and long-term effects of EFT, as well as to identify factors that influence its effectiveness.
Imagining the future can shape the present: A systematic review of the impact of episodic future thinking on substance use outcomes.Collado, A., Stokes, A.[2023]

References

Episodic future thinking for smoking cessation in individuals with substance use disorder: Treatment feasibility and acceptability. [2021]
Episodic Future Thinking about Smoking-Related Illness: A Preliminary Investigation of Effects on Delay Discounting, Cigarette Craving, and Cigarette Demand. [2022]
Imagining the future can shape the present: A systematic review of the impact of episodic future thinking on substance use outcomes. [2023]
Contingency management for smoking cessation among individuals with substance use disorders: In-treatment and post-treatment effects. [2021]
Internal Validity of Two Promising Methods of Altering Temporal Orientation among Cigarette Smokers. [2021]
Psychopathology and episodic future thinking: A systematic review and meta-analysis of specificity and episodic detail. [2019]
Putting prospection into practice: Methodological considerations in the use of episodic future thinking to reduce delay discounting and maladaptive health behaviors. [2023]
[Smoking cessation with special focus on primary health care]. [2019]
Mindfulness for smoking cessation. [2023]
Applying a new theory to smoking cessation: case of multi-theory model (MTM) for health behavior change. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Cognitive Behavioral and Mindfulness-Based Interventions for Smoking Cessation: a Review of the Recent Literature. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Behavioral tobacco cessation treatments: yesterday's news or tomorrow's headlines? [2007]